List view / Grid view
10 December 2018 | By European Pharmaceutical Review
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
10 December 2018 | By European Pharmaceutical Review
A dementia drug has been given Orphan Drug Designation by the FDA, meaning this special status will qualify sponsors of the drug for development incentives.
7 December 2018 | By European Pharmaceutical Review
A study has shown that thousands of heart attacks and deaths caused by cardiovascular disease could be prevented through the use of statins...
7 December 2018 | By European Pharmaceutical Review
Oxybutynin could help breast cancer survivors who are affected by increased hot flushes through cancer treatment, improving their quality of life...
7 December 2018 | By Pharmapack Europe
In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe reports that innovation is also accelerating across the drug delivery and packaging industries...
6 December 2018 | By European Pharmaceutical Review
The US FDA has announced that it will confirm the capability of five more countries to carry out good manufacturing practice (GMP)...
6 December 2018 | By CPhI India
CPhI & P-MEC India opens as report ranks India the world’s fastest improving pharma market and first for ‘growth potential’ for 2019...
6 December 2018 | By European Pharmaceutical Review
Research into detecting tau proteins in the brains of Alzheimer's patients has shown that a specific tracer could detect and measure the protein levels...
5 December 2018 | By European Pharmaceutical Review
A phase III clinical trial showed that neoadjuvant chemotherapy and trastuzumab reduced the risk of recurrence of HER2-positive early-stage breast cancer...
5 December 2018 | By Iqra Farooq (European Pharmaceutical Review)
A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients...
4 December 2018 | By European Pharmaceutical Review
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
4 December 2018 | By European Pharmaceutical Review
The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year...
3 December 2018 | By European Pharmaceutical Review
Researchers have developed a method of using less contrast medium to still obtain high quality images in magnetic resonance imaging (MRI)...
3 December 2018 | By European Pharmaceutical Review
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...
30 November 2018 | By European Pharmaceutical Review
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
Follow: